Refine
Document Type
- Doctoral Thesis (22)
Has Fulltext
- yes (22)
Is part of the Bibliography
- no (22)
Keywords
- Virologie (4)
- Apoptosis (3)
- Aviäre Influenza (3)
- Proteomanalyse (3)
- ASFV (2)
- Afrikanische Schweinepest (2)
- Apoptose (2)
- Arenaviren (2)
- Arenavirus (2)
- Herpesviren (2)
Ebolaviruses are dependent on host cell proteins for almost all steps in their viral life cycle. While some cellular factors with crucial roles in the ebolavirus life cycle have been identified, many of them remain to be identified or fully characterised. This thesis focuses on the characterisation and identification of host cell interactions of the highly pathogenic Ebola virus (EBOV), probing host-virus interaction at various stages of the viral life cycle. Beginning with viral budding, the function of a recently proposed late domain motif within the EBOV matrix protein VP40 was examined using an EBOV transcription and replication-competent virus-like particle (trVLP) system. Although this motif has been suggested to interact with the endosomal sorting complex required for transport (ESCRT), we could show that this late domain motif does not contribute to EBOV budding.
While many host cell proteins have been identified so far that are important for viral budding, only a few proteins are known that are necessary for EBOV RNA synthesis. Thus, to identify host proteins that are involved in viral replication and transcription, we performed a genome-wide siRNA screen in the context of an EBOV minigenome assay. Using this approach, we identified several proteins that appear to be important for viral RNA synthesis or protein expression. Two of the most prominent hits in our screen were CAD (Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase and dihydroorotase) and NXF1 (nuclear RNA export factor 1). CAD catalyses the first three steps in the de novo pyrimidine biosynthesis, while NXF1 is the main nuclear export protein for cellular mRNAs. In subsequent characterisation studies, using a range of life cycle modelling systems as well as molecular analyses, we could demonstrate that the canonical function of CAD during the pyrimidine biosynthesis is necessary for EBOV replication and transcription. In contrast to this, for NXF1 we discovered a so-far unknown function: Again, by applying different life cycle modelling alongside with molecular assays, we provided evidence that the EBOV nucleoprotein recruits NXF1 into inclusion bodies, the site of EBOV RNA synthesis, where it binds viral mRNAs to export them from these structures. Importantly, for both CAD and NXF1 we were able to recapitulate key data in the context of live EBOV infection, confirming their roles in the viral life cycle.
Both of these identified host factors are promising targets for antiviral therapies and indeed de novo pyrimidine synthesis is emerging as a possible antiviral target for a number of viruses. Similarly, as we could show NXF1 to be important in the life cycle of the highly pathogenic Junín virus, this raises the possibility that disruption of this interaction may result in broad-spectrum antiviral activity. Moreover, for an increasing number of negative-sense RNA viruses inclusion bodies as site of viral RNA synthesis are described to have a liquid organelle character. Therefore, our findings on NXF1 also provide an intriguing model to explain how negative-sense RNA viruses in general overcome this obstacle and export viral mRNAs from inclusion bodies.
Coding constraints imposed by the very small genome sizes of negative-strand RNA viruses (NSVs) have led to the development of numerous strategies that increase viral protein diversity, enabling the virus to both establish a productive viral replication cycle and effectively control the host antiviral response. Arenaviruses are no exception to this, and previous findings have demonstrated that the nucleoprotein (NP) of the highly pathogenic Junín virus (JUNV) exists as three additional N-terminally truncated isoforms of 53 kD (NP53kD), 47 kD (NP47kD), and 40 kD (NP40kD). The two smaller isoforms (i.e. NP47kD and NP40kD) have been characterized as products of caspase cleavage, which appears to serve a decoy function to inhibit apoptosis induction. However, whether they have additional functions in the viral replication cycle remains unknown. Further, the origin and function of NP53kD has not yet been described.
In order to first identify the mechanism responsible for production of the NP53kD variant, a possible role of additional caspase cleavage sites was first excluded using a site mutagenesis approach. Subsequently, alanine mutagenesis was then used to identify a region responsible for NP53kD production. As a result, three methionine residues were identified within the characterized sequence segment of NP, linking the production of NP53kD to an alternative in-frame translation initiation. Further site-directed mutagenesis of the previously identified putative in-frame methionine codons (i.e. M78, M80 and M100) finally led to the identification of translation initiation at M80 as being predominantly responsible for the production of NP53kD. Once the identity of all three NP isoforms was known, it was then of further interest to more deeply characterize their functional roles. Consistent with the N-terminal domain containing RNA binding and homotrimerization motifs that are relevant for the viral RNA synthesis process, it could be demonstrated that all three truncated NP isoforms lost the ability to support viral RNA synthesis in a minigenome assay. However, they also did not interfere with viral RNA synthesis by full-length NP, nor did they affect the ability of the matrix protein Z to inhibit viral RNA synthesis. Moreover, it was observed that loss of the oligomerization motifs in the N-terminus also affected the subcellular localization of all three NP isoforms, which were no longer localized in discrete perinuclear inclusion bodies, but rather showed a diffuse distribution throughout the cytoplasm, with the smallest isoform NP40kD also being able to enter the nucleus. Surprisingly, the 3'-5' exonuclease function of NP, which is associated with the C-terminal domain and plays a role in inhibiting interferon induction by digestion of double-stranded RNAs, was found to be retained only by the NP40kD isoform, despite that all three isoforms retained the associated domain. Finally, previous studies using transfected NP and chemical induction of apoptosis have suggested that cleavage of NP at the caspase motifs responsible for generating NP47kD and NP40kD plays a role in controlling activation of the apoptosis pathway. Therefore, to further characterize the connection between the generation of NP isoforms and the regulation of apoptosis in a viral context, recombinant JUNVs deficient in the respective isoforms were generated. Unlike infections with wild-type JUNV, mutations of the caspase cleavage sites resulted in the induction of caspases activation. Surprisingly, however, this was also the case for mutation of the alternate start codon responsible for NP53kD generation.
Taken together, the data from this study suggest a model whereby JUNV generates a pool of smaller NP isoforms with a predominantly cytoplasmic distribution. As a result of this altered localization, NP53kD appears to be able to serve as the substrate for further generation of NP47kD and NP40kD by caspase cleavage. Not only does this cleavage inhibit apoptosis induction during JUNV infection, it also results in a cytoplasmic isoform of NP that retains strong 3'-5' exonuclease activity (i.e. NP40kD) and thus may play an important role in preventing viral double-stranded RNA accumulation in the cytoplasm, where it can lead to activation of IFN signaling. Overall, such results emphasize the relevance of alternative protein isoforms in virus biology, and particularly in regulation of the host response to infection.
Viral diseases are a threat to bacteria and enormous animals alike. Vaccines are available against several viruses. However, for some viruses, like ASFV, we still lack vaccines, while for others, like IAV, they are not as effective as we need them to be. To a large extent, this is because we do not fully understand the mechanisms conferring antiviral immunity. To improve our understanding of antiviral immunity, we used a model species that is in many immunological aspects closer to humans than the widely used laboratory mice, pigs. In this thesis, pigs were investigated as a potential biomedical model species for viral respiratory infections in humans and as a natural host for viral infections. Both approaches provide valuable insights into aspects of porcine immunology that can either be used as the foundation for translational research or for the design of targeted therapeutics and vaccines for pigs.
Insights into fundamental characteristics of the porcine immune system form the basis for translational studies. Paper I pioneered a detailed characterization of porcine iNKT cells. To make pigs and porcine iNKT cells more available for scientific investigations, we established multicolor flow cytometry analysis platforms that allow for a more detailed investigation of these cells than previously possible. We found porcine iNKT cells circulating in peripheral blood to be a rare population among CD3+ lymphocytes that displays a pre-activated effector state and can be divided into at least three functional subsets. Upon antigenic activation, they proliferated rapidly, secreted pro-inflammatory cytokines, and exerted cytotoxicity. Moreover, we provided first evidence for a role of iNKT cells in porcine IAV and ASFV infections, which we investigated in more detail in paper IV. Central characteristics, i.e., phenotype and functional properties, exhibit a high degree of similarity between humans and pigs. Moreover, differences between human and murine iNKT cells are more pronounced than between humans and pigs.
Based on the results obtained in paper II, the established biomedical model could be used for further studies of infectious respiratory diseases. IAV infections pave the way for secondary co-infections with increased morbidity and lethality. These bactoviral co-infections are a threat to both pigs and humans. The shared susceptibility as well as homologies on the physiological and immunological level make pigs exceptionally suitable animal models for studies of these infections. Paper I and II can also be interpreted under translational aspects. Activation of iNKT cells in porcine vaccination studies showed promising results. Based on these and our findings, this might be a suitable approach for humans as well. Along with other studies, our results suggest that pigs might be a well-suited large animal model for research in infectious diseases. This is true especially for respiratory infections, such as seasonal IAV infections, for which pigs are natural hosts and contribute to viral spread and emergence as “mixing vessels”, which can result in pandemic strains like H1N1pdm09. We could show that porcine iNKT cells as well as the antiviral responses of cTC against H1N1pdm09 in pigs are comparable to human cells and processes. The increased implementation of pigs in basic and applied research might enable an improved translation of scientific knowledge to human and veterinary medicine.
In two further studies, papers III and IV, we investigated T-cell responses during a viral infection, ASF, for which pigs are the only natural hosts. Immune responses were similar after highly and moderately virulent ASFV infection in domestic pigs and wild boar, respectively. However, they differed between both species. Antiviral immunity in domestic pigs was predominantly exerted by αβ T cells, CD8α+ and DP αβ T cells, while the response in wild boar was dominated by γδ T cells, mainly CD8α+ effector cells. Since wild boar show a higher disease severity and lethality, even during infection with moderately virulent ASFV “Estonia2014”, a shift to γδ T cells seems to be detrimental. In contrast, domestic pigs survive infections with moderately virulent ASFV “Estonia2014”, which indicates that CD8α+ or DP αβ T cells confer protection at least in infections with non-highly virulent ASFV strains. Interestingly, in paper V we found higher and prolonged inflammation in domestic pigs, correlating with increased T-cell influx. However, histopathological analyses revealed no direct explanation for the differences in disease progression and lethality in domestic pigs and wild boar. These findings require further studies to elucidate the underlying mechanisms.
The lack of basic data about immunological differences between domestic pigs and wild boar hampers attempts to understand immunity against ASFV. We found differences between both suid subspecies already at steady state and even more prominent during ASFV infections in papers III-V. Most apparently, T-cell responses in wild boar were heavily biased towards γδ T cells, while immune responses in domestic pigs were based on αβ T cells. However, information about even basic characteristics, like the composition, phenotypes, and functional qualities of wild boar’s immune system, is missing. Therefore, essential baseline data must be obtained in order to adequately assess changes in future studies.
Analyses like these reveal major advantages of pigs as a biomedical model. On the one hand, similar to conventional model species, researchers can investigate every tissue at any desired time. Tissue from human patients is often scarce or not at all available, so models that can be investigated at specific times after infection are needed. On the other hand, results obtained in pigs are more comparable to humans than data from murine studies. Moreover, pigs are susceptible to similar pathogens as humans and experimental infections can be investigated without the need for major genetic manipulations. However, there are also limitations of the porcine model system. Analysis tools are not as advanced as they are for mice, especially in terms of availability of mAbs or genetically modified organisms. Still, given the major advantages that become more and more obvious, efforts should be made to make pigs more applicable for basic and translational research. In addition, findings derived from pigs can be used for the species itself. Pigs are a major livestock species and new treatments, or vaccines could also be used for them. Therefore, this research could eventually also improve animal welfare.
In summary, the presented thesis significantly enhanced our knowledge of porcine immune processes for cTC in general and iNKT cells in particular. Results were obtained both at steady state and in the context of IAV and ASFV infections, and thus, made pigs more available as a model for future research. The use of multicolor flow cytometry provided a broad overview of the ongoing immune reactions and enables further, more wide-ranging studies that can also address open questions in even more complex infection scenarios.
Avian influenza viruses (AIVs) have their natural reservoir in wild aquatic birds but occasionally
spread to terrestrial poultry. While AIVs of subtypes H5 and H7 are well known to evolve highly
pathogenic avian influenza viruses (HPAIVs) during circulation in domestic birds, non-H5/H7
subtypes exhibit only a low to moderate pathogenicity. Furthermore, spillover events to a broad
range of mammalian hosts, including humans, with self-limiting to severe illness or even fatal
outcomes, were reported for non-H5/H7 AIVs and pose a pandemic risk. The evolution of high
virulent phenotypes in poultry and the adaptation of AIVs to mammalian hosts are predominantly
linked to genetic determinants in the hemagglutinin (HA). The acquisition of a polybasic cleavage
site (pCS) is a prerequisite for the evolution of HPAIVs in poultry, while changes in the receptor
binding preference and virus stability are essential for adaptation of AIVs to mammals.
In August 2012, an H4N2 virus with the pCS motif 322PEKRRTR/G329 but preserved trypsin
dependend replication and low pathogenicity in chickens was isolated on a quail farm in California.
In the first two publications, we followed different approaches to investigate virulence factors and
the potential risk for the transition of H4N2 to high virulence in chickens. The loss of N-terminal
glycosylations in the vicinity of the pCS resulted in decreased binding to avian-like receptors and
dramatically decreased virus stability. On the other hand, one deglycosylation increased virus
replication and tissue tropism in chicken embryos but did not alter virulence or excretion in
chickens. Furthermore, additional basic amino acids in the natural pCS motif improved the trypsin-independent
cleavage of HA and caused slightly increased tissue tropism in chickens. However,
the engineered motifs alone did not affect virulence in chickens. Intriguingly, they even had a
detrimental effect on virus fitness, which was restored after reassortment with segments of HPAIV
H5N1. Together, the results show the importance of HA glycosylations on the stability of H4N2 and
reveal the important role of non-HA segments in the transition of this virus to high virulence in
poultry.
The transmission of another non-H5/H7 AIV of subtype H10N7 from birds to seals resulted in mass
deaths in harbor seals in 2014 in northern Europe. The third publication describes nine mutations
in the HA1 subunit of seal isolates compared to avian H10Nx viruses. We found that some of these
mutations conferred a dual specificity for avian and mammalian receptors and altered
thermostability. Nevertheless, the H10N7seal remained more adapted to avian host cells, despite
of the alteration in the receptor binding specificity.
Altogether, this thesis demonstrates that naturally evolved AIVs beside H5 and H7 subtypes
support a highly pathogenic phenotype in the appropriate viral background and alter virulence and
host receptor specificity by few amino acid substitutions in the HA. These findings improve our
knowledge of the potential of non-H5/H7 AIVs to shift to high virulence in birds and the adaptation
in mammals.
LPAIV H9N2 and HPAIV H5N8 clade 2.3.4.4 viruses have been frequently isolated from domestic and wild birds in Germany and they are endemic in poultry worldwide. H9N2 is known to donate gene segments to other AIV with high case fatality rate in humans (e.g. H5N1, H7N9). Similarly, H5N8 devastated poultry worldwide since 2014 and has been recently isolated from humans. Therefore, it is important to understand the genetic predisposition for adaptation of H9N2 and H5N8 AIV in poultry and mammals. In the first publication, we focused on the variable hemagglutinin cleavage site (HACS) of European and Non-European H9N2 viruses, since the HACS is a main virulence determinant of AIV in birds. We found a preferential substitution of non-basic amino acids (G, A, N, S, D, K) in the HACS at position 319 of European H9N2 viruses compared to non-European H9N2 viruses. Recombinant viruses carrying different non-basic amino acids in the HACS modulated replication in vitro. While these non-basic amino acids did not affect virulence or transmission in chickens, they modulated virulence and replication in turkeys. Moreover, H9N2 viruses with non-basic amino acids in the HACS were able to replicate in mammalian brain cells for multiple cycles even without trypsin. In the second publication, we addressed the question whether reassortment between two recent German H9N2 and H5N8 clade 2.3.4.4. B viruses is possible and analysed the impact on virus fitness in mammals and birds. We found that H9N2 PB1 and NP segments were not compatible to generate infectious H5N8 viruses and this incompatibility was due to mutations outside the packaging region. However, H9N2 NS alone or in combination with PB2 and PA significantly increased replication of H5N8 in human cells. Moreover, H9N2 PB2, PA and/or NS segments increased virulence of H5N8 in mice. Interestingly, in chickens, reassortment with H9N2 gene segments, particularly NS, partially or fully impaired chicken-to-chicken transmission. These results indicate that the evolution of H9N2/H5N8 reassortants showing high virulence for mammals is unlikely to occur in chickens. In the third publication, we focused on the NS1 protein of different HPAIV H5N8 clade 2.3.4.4 viruses from 2013 to 2019 and studied the impact of its C-terminus (CTE) variation on virus fitness in chickens and ducks. Our findings revealed a preferential selection for a certain NS1 CTE length in 2.3.4.4. H5N8 clade A (237 aa) and B (217 aa) viruses over the common length of 230 aa. Indeed, the NS1 CTE can affect virus virulence and pathogenesis in a species and virus clade dependent manner. In chickens, although there was no impact on virulence, NS1 CTE of H5N8-A and H5N8-B, regardless of the length, have evolved towards higher efficiency to block the IFN response. In ducks, NS1 CTE contributed to efficient transmission, replication and high virulence of H5N8-B. In the fourth publication, we assessed the impact of variable length of NS1 on H5N8 virus replication in human cells and virulence in mice. We showed that NS1 of H5N8-B virus unlike the vast majority of NS1 of AIV, shared preferences for short NS1 similar to human and zoonotic influenza viruses. This virus (i) was able to efficiently block IFN and apoptosis induction which might be the first steps for efficient adaptation to human cells and (ii) without prior adaptation replicated at higher levels and was more virulent in mice than H5N8-A. The virulence of the latter virus increased after shortening the NS1 similar to H5N8-B virus. Therefore, it is conceivable that truncation in NS1 is a determinant for adaptation of H5N8 in mammals irrespective of its impact on virus fitness in poultry. Findings in this dissertation indicated that HA mutations in the European H9N2 and NS1 variations in H5N8 viruses play a role in virus fitness in poultry and/or mammals. These results improve our current understanding for AIV adaptation and are useful to assess the potential of these viruses to infect mammals.
Herpesviruses are enveloped DNA viruses which are dependent on two fusion steps for efficient replication in the host cell. First, they have to fuse their envelope with the cellular plasma membrane or with the vesicle membrane after endocytic uptake to enter the host cell and second, they have to export the newly generated nucleocapsids from the site of assembly to the cytoplasm by fusion of the primary virion envelope with the outer nuclear membrane (ONM). The main goal of this project was to provide a better understanding of how herpesvirus capsids exit the nucleus. On the one hand this thesis aimed at finding cellular proteins involved in nuclear egress (Paper I), while on the other the focus was on further characterization of the viral nuclear egress complex (NEC, Paper II) and its interaction with the capsid (Paper III).
It is the hallmark of viruses, including herpesviruses, to hijack host cell proteins for their efficient replication. Some of those interactions are well characterized, while others might not yet have been discovered. In the last step of the nuclear egress, where the primary virion membrane fuses with the ONM, most likely a cellular machinery is involved. The presented work focused on Torsin, the only known AAA+ ATPase localizing in the endoplasmic reticulum and the perinuclear space (PNS). For this, the effect of overexpression of WT and mutant proteins, as well as CRISPR/Cas9 generated knock-out cell lines, on PrV replication was analyzed. Neither single overexpression nor single knockouts of TorA or TorB had any significant effects on virus titers. However, infection of TorA/B double knockout cells revealed reduced viral titers and an accumulation of primary virions in the PNS at early infection times, indicating a delay in nuclear egress.
The process of nuclear egress has been intensively investigated without revealing all its details. To address some of the missing aspects we generated monoclonal antibodies (mAbs) against the NEC and its components (pUL31 and pUL34) for a better visualization of the process in transfected as well as infected cells. These mAbs provide a useful tool for future analyses.
The publication of the NEC crystal structure formed the basis for intensive research on the molecular details of the NEC formation and its interaction with the nucleocapsid. Recently, our lab showed that lysine (K) at position 242 in the membrane-distal part of pUL31 is crucial for incorporation of the nucleocapsid into budding vesicles. Replacing K by alanine (A) resulted in accumulations of vesicles in the PNS, while mature capsids were not incorporated. To test whether this is due to electrostatic interference or structural restrictions we substituted K242 by different aa to determine the requirements for nucleocapsid uptake into the nascent primary particles. To analyze whether the defect of pUL31-K242A can be compensated by second-site mutations, PrV-UL31-K242A was passaged and mutations in revertants were analyzed. Different mutations have been identified compensating for the K242A defect. A considerable number of mutations indicates that the NEC is much more flexible than previously thought. Further, we gained information that the K at position 242 is not directly involved in capsid interaction, while it is more likely involved in rearrangements within the NEC coat.
Herstellung sicherer und wirksamer Lebendvakzine gegen die Koi Herpesvirus Infektion von Karpfen
(2019)
Das Koi Herpesvirus (KHV, Cyprinid herpesvirus 3) verursacht eine tödliche Erkrankung bei Kois und Karpfen. Um sichere und wirksame Lebendvirusimpfstoffe zu erhalten, haben wir Einzel- und Doppeldeletionsmutanten von KHV erzeugt, aus deren Genom die für die beiden Nukleotidstoffwechselenzyme Thymidinkinase (TK, ORF55) und Desoxyuridin-Triphosphatase (DUT, ORF123) codierenden Leserahmen gezielt entfernt worden waren. Die Mutationen wurden durch homologe Rekombination in den zellkulturadaptierten aber noch virulenten Stamm KHV-T eingeführt. Umfangreiche in vitro Tests zeigten, dass die Deletion der TK- und DUT- Gene die KHV-Replikation in Zellkultur (CCB Zellen) nicht erkennbar beeinträchtigt. In vivo Tests an Jungkarpfen zeigten jedoch eine im Vergleich zum Ausgangsvirus signifikant reduzierte Virulenz der Einzelgen-Deletionsmutanten eine fast vollständige Attenuierung der Doppelmutante. Dennoch waren alle immunisierten Karpfen gegen eine letale Belastungsinfektion mit virulentem KHV geschützt. Mittels einer neu entwickelten Triplex-Real-Time-PCR und aus Kiementupferproben isolierter DNA war es möglich, mit TK-negativem KHV immunisierte und Wildtyp- infizierte Karpfen zu differenzieren. Daher könnte die Doppelmutante KHV- TΔDUT/TK als genetischer Marker-Impfstoff geeignet sein.
In einer zweiten Studie wurde die Funktion von vier immunogenen Hüllglykoproteinen der ORF25-Genfamilie (ORF25, ORF65, ORF148 und ORF149) von KHV untersucht. Hierbei wurde festgestellt, dass alle vier Gene für die Virusreplikation in Zellkultur entbehrlich sind. Während die Deletion von ORF65 keinen erkennbaren Einfluss auf die Virusvermehrung hatte, führte die Deletion von ORF148 sogar zu einer leicht erhöhten Replikationsrate. Im Gegensatz dazu bewirkten Deletionen von ORF25 oder ORF149 einen verzögerten Eintritt in die Wirtszellen und damit auch eine verlangsamte Vermehrung und Ausbreitung der Viren. Interessanterweise führte die gemeinsame Deletion der Gene ORF148 und
ORF149 zu einem wildtypähnlichen Wachstumsverhalten, das auf gegensätzlicher Funktionen der beiden Proteine hindeutete. Elektronenmikroskopische Untersuchungen von CCB-Zellen, die mit den verschiedenen Glykoproteindeletionsmutanten infiziert waren, zeigten keine Auswirkungen auf die Bildung und Reifung der Virionen im Zellkern oder im Zytoplasma, oder die Virusfreisetzung. Im Tierversuch erwiesen sich KHV-Mutanten mit Deletionen der Gene ORF148 und/oder ORF149 als geringfügig, aber für eine Verwendung als Lebendvirus-Impfstoff nicht ausreichend abgeschwächt. Überlebende Fische waren jedoch gegen Belastungsinfektionen ebenso gut geschützt wie Wildtyp-infizierte Karpfen, so dass die Deletion dieser antikörperinduzierenden Proteine zur Entwicklung von KHV-Markerimpfstoffen beitragen könnte, die eine serologische Differenzierung von Wildtyp-infizierten und geimpften Fischen erlauben (DIVA- Prinzip). In einer dritten Studie wurden durch serielle Zellkulturpassage von virulentem KHV und anschließende in vivo Infektionsversuche Hinweise darauf gefunden, dass das bislang nicht näher charakterisierte, neben dem ORF149 Gen lokalisierte ORF150 für einen weiteren Virulenzfaktor von KHV codiert. Möglicherweise könnte also durch eine kombinierte Deletion der im Rahmen dieser Arbeit untersuchten KHV-Gene ein sicherer und wirksamer, genetisch und serologisch differenzierbarer Markerimpfstoff hergestellt werden.
Infectious diseases remain a significant threat to the wellbeing of humans and animals
worldwide. Thus, infectious disease outbreaks should be investigated to understand the
emergence of these pathogens, leading to prevention and mitigation strategies for future
outbreaks. High-throughput sequencing (HTS) and bioinformatic analysis tools are reshaping
the surveillance of viral infectious diseases through genome-based outbreak investigations. In
particular, analyzing generic HTS datasets using a metagenomic analysis pipeline enable
simultaneous identification, characterization, and discovery of pathogens.
In this thesis, generic HTS datasets derived from the 2018-19 WNV epidemic and USUV
epizooty in Germany were evaluated using a unified pipeline for outbreak investigation and an
early warning system (EWS). This pipeline obtained 34 West Nile virus (WNV) whole-genome
sequences and detected several sequences of Usutu virus (USUV) and other potential
pathogens. A few WNV and USUV genome sequences were completed using targeted HTS
approaches. Phylogenetic and phylogeographic inferences, reconstructed using WNV wholegenome sequences, revealed that Germany experienced at least six WNV introduction events.
The majority of WNV German variants clustered into the so-called “Eastern German clade
(EGC),” consisting of variants derived from birds, mosquitoes, a horse, and human cases. The
progenitors of the EGC subclade probably circulated within Eastern Europe around 2011. These
flavivirus genome sequences also provided substantial evidence for the first reported cases of
WNV and USUV co-infection in birds. Phylogenetic inferences of USUV genome sequences
showed the further spread of the USUV lineage Africa 3 and might indicate the overwintering
of the USUV lineage Europe 2 in Germany. Among viral sequences reported in the EWS, Hedwig
virus (HEDV; a novel peribunyavirus) and Umatilla virus (UMAV; detected in Europe for the
first time) were investigated using genome characterization, molecular-based screening, and
virus cultivation since these viruses were suspected of causing co-infections in WNV-infected
birds. The EWS detected overall 8 HEDV-positive and 15 UMAV-positive birds in small sets of
samples, and UMAV could be propagated in a mosquito cell culture Future studies are necessary
to investigate the pathogenicity of these viruses and their role in the health of wild and captive
birds.
In conclusion, this study provided a proof-of-concept that the developed unified and
generic pipeline is an effective tool for outbreak investigation and pathogen discovery using the
same generic HTS datasets derived from outbreak and surveillance samples. Therefore, this
thesis recommends incorporating the unified pipeline in the key response to viral outbreaks to
enhance outbreak preparedness and response.
Herpesviruses are a fascinating group of enveloped DNA viruses, which rely on membrane fusion for infectious entry and direct cell-to-cell spread. Compared with many other enveloped viruses, they utilize a remarkably complex fusion machinery. Three conserved virion proteins, the bona fide fusion protein gB, and the presumably gB activating gH/gL heterodimer constitute the conserved core fusion machinery and are believed to drive membrane fusion in a cascade-like fashion. Activation of this cascade in most alphaherpesviruses is proposed to be triggered by binding of gD to specific host cell receptors. The molecular details of this fusion process, however, remain largely elusive. Yet, a detailed mechanistic knowledge of this process would be greatly beneficial for the development of efficient countermeasures against a variety of diseases. In this thesis, the functional relevance of individual components of the essential gH/gL complex of the alphaherpesvirus PrV has been assessed by two different approaches: by reversion analysis (paper II) and site-directed mutagenesis (papers III-V). In contrast to other herpesviruses, gL-deleted PrV is able to perform limited cell-to-cell spread, providing the unique opportunity to passage the entry-deficient virus in cell culture to select for PrV revertants capable of infecting cells gL-independently. This approach already resulted in an infectious gL-negative PrV mutant (PrV-ΔgLPass), in which the function of gL was compensated by formation of a gDgH hybrid protein. Here, the requirements for gL-independent infectivity of a second independent revertant (PrV-ΔgLPassB4.1), were analyzed. Sequencing of the genes encoding for gB, gH and gD, revealed mutations in each of them. By means of a robust infection-free, transfection-based cell-cell fusion assay (paper I), we identified two amino acid substitutions in the gL-binding domain I of gHB4.1 (L70P, W103R) as sufficient to compensate for lack of gL. Two mutations in gB (G672R, ΔK883) were found to enhance fusogenicity, probably by lowering the energy, required for gB refolding from pre- to postfusion conformation. Coexpression of gHB4.1 and gBB4.1 led to an excess fusion, which was completely suppressed by gDB4.1 in the fusion assays. This was surprising since PrV gD is normally not required for in vitro fusion or direct viral cell-to-cell spread, clearly separating this process from fusion during entry, for which PrV gD is essential. The fusion inhibiting effect of gDB4.1 could be attributed to a single point mutation resulting in an amino acid substitution within the ectodomain (A106V). In conclusion, these results indicated that gL is not central to the fusion process, as its function can be compensated for. As found so far, gL-independent infectivity can be realized by compensatory mutations in gH (as in PrV-ΔgLPass) or in gH plus gB (as in PrV-ΔgLPassB4.1). Excessive fusion induced by gHB4.1 and gBB4.1 was counter-regulated by gDB4.1, indicating that the interplay between these proteins is precisely regulated and further implies that gL and gD, despite being not absolutely essential for the fusion process, have important regulatory functions on gH and/or gB.
Both PrV-ΔgLPass mutants had acquired compensatory mutations in gH affecting the predicted gL-binding domain I in gH. By construction of an artificial gH32/98, which lacked the predicted gL-binding domain and was similar to the recently crystallized gH-core fragment present in the gDgH hybrid protein, we identified the N-terminal part of PrV gH as essential for gH function during fusion (paper III). gH32/98 was unable to promote fusion of wild-type gB in fusion assays and led to a total loss of function in the viral context. These results indicated that the gD moiety, present in gDgH, is critical for proper function of the gH-core fragment. We hypothesize that the gD moiety may adopt a stabilizing or modulating influence on the gH structure, which is normally executed by gL and important for interaction of gH with wild-type gB. Remarkably, substitution of wild-type gB by gBB4.1 rescued function of gH32/98 in the cellular and viral contexts. These findings suggest that gBB4.1 has been selected for interaction with “gL-less” gH. In conclusion, these results demonstrated that gL and the gL-binding domain are not strictly required for membrane fusion during virus entry and spread but that compensatory mutations must be present in gB to restore a fully functional fusion machinery. These results strongly support the notion of a functional gH-gB interaction as a prerequisite for membrane fusion.
In addition to the N-terminal domain, we identified the transmembrane domain of PrV gH as an essential component of the fusion machinery, while the cytoplasmic domain was demonstrated to play a modulatory but nonessential role (paper IV). Whereas truncation or substitution of the PrV gH TMD by a gpi-anchor or the analogous sequence from PrV gD rendered gH non-functional, the HSV-1 gH TMD was found to functionally substitute for the PrV gH TMD in cell-cell fusion and complementation assays. Since residues in the TMD which are conserved between HSV and PrV gH but absent in PrV gD, are placed on one face of an α-helical wheel plot, we hypothesize that the gH TMD has an intrinsic property to interact with membrane components such as lipids or other molecules as a requirement for promoting membrane fusion.
In a final study focusing on the function of gH, we identified the N-glycosylation sites utilized by PrV gH, and determined their individual role in viral infection (paper V). PrV gH was found to be modified by N-glycans at five potential glycosylation sites. N-glycans at PrV specific N77 and the highly conserved site N627 were found to be critical for efficient membrane fusion in the fusion assays, and during viral entry and cell-to-cell spread. N627 was further shown to be crucial for proper gH transport and maturation. In contrast, inactivation of N604, conserved in the Varicellovirus genus, enhanced in vitro fusion activity and viral cell-to-cell spread. These findings demonstrated a role of the N-glycans in proper localization and function of PrV gH.
New World arenaviruses represent an important group of zoonotic pathogens that pose a serious threat to human health. While some virus species cause severe disease, resulting in hemorrhagic fever and neurological symptoms, other closely related family members exhibit little or no pathogenicity. For instance, Junín virus (JUNV) is the causative agent of Argentine hemorrhagic fever, while the closely related Tacaribe virus (TCRV) is avirulent in humans. Little is known about host cell responses to infection, or how they contribute to virulence; however, TCRV strongly induces caspase-dependent apoptosis (i.e. non-inflammatory programmed cell death) in infected cells, whereas JUNV does not.
In order to better understand the connection between apoptosis and pathogenesis, we sought to unravel the regulation of pro- and anti-apoptotic signaling in response to arenavirus infection. We demonstrated that apoptosis induced by TCRV proceeds over the mitochondrial-regulated intrinsic pathway and involves activation of p53 (accumulation and phosphorylation), activation of the pro-apoptotic BH3-only factors Puma and Noxa (accumulation), as well as inactivation of another pro-apoptotic factor called Bad (phosphorylation). The regulation of these factors in response to TCRV infection is accompanied by other classical hallmarks of intrinsic apoptosis, such as disorganization of the mitochondrial network, cytochrome c release, PS flipping, caspase cleavage and nuclear condensation. The involvement of the BH3-only factors as key players in regulating TCRV-induced apoptosis could also be validated in knockout cells, which showed either suppressed or increased apoptosis depending on the respective activation (i.e. Puma and Noxa) or inactivation (i.e. Bad) status of the respective BH3 protein. Interestingly, while JUNV does not trigger late stages of apoptosis induction (i.e. caspase activation, nuclear condensation and cell death), we could show that it activates similar upstream pro-apoptotic signaling events including activation of p53, Puma and Noxa. This supports the current hypothesis that JUNV actively evades the induction of apoptosis through the involvement of a mechanism targeting late steps in the apoptotic cascade. Specifically, this model proposes that intrinsic activation is suppressed at the level of caspase activation by JUNV NP, which serves as an alternative substrate for caspase cleavage.
Additionally, in order to identify viral factors associated with the induction of apoptosis, a full genome sequencing of TCRV was performed and contributed to the validation and correction of substantial errors reported in existing sequences for TCRV. With the help of this sequence, correct expression plasmids containing the viral genes for NP, GP and Z were constructed and tested for their ability to induce apoptosis in vitro. This revealed that both TCRV and JUNV Z are triggers for apoptosis, which further supports our finding that JUNV also induces activation of pro-apoptotic factors. Again, consistent with a model where JUNV NP blocks caspase activation directly, co-expression of JUNV Z and NP abrogated caspase activation, while simultaneous expression of TCRV NP and Z still resulted in cell death.
Finally, identification of the specific apoptotic factors involved in regulating TCRV-induced apoptosis (i.e. Bad, Puma and Noxa) and the generation of the respective knockout cell lines allowed us to investigate what influence apoptosis induction has on virus infection. Interestingly, knockout of these factors showed no direct impact on virus growth in Vero cells. However, TCRV particles produced in cells with the individual pro-apoptotic (i.e. Puma and Noxa) or anti-apoptotic (i.e. Bad) factors knocked out showed altered infectivity in primary human monocytes and macrophages, which represent important target cells for arenaviruses. Since TCRV particles that originate from the different knockout cells would be expected to contain different amounts of PS in their envelope (depending on the level of apoptosis taking place), this suggests a role of apoptosis in facilitating PS-receptor-mediated entry and/or PS-receptor signaling through downstream kinases, either of which could be contributing to successful infection in professional phagocytic cells. In particular, phosphorylation of some of the identified factors involved in regulating TCRV-induced apoptosis indicates the involvement of upstream kinases from diverse signaling pathways, some of which also play a role in regulating cytokine production – another host cell reaction that differs significantly between TCRV- and JUNV-infected monocytes and macrophages. As such, these findings represent an exciting basis for a possible connection between apoptotic responses and the regulation of pro- and anti-inflammatory cytokine responses via their associated upstream signaling processes and provide a starting point for future studies that will help us to better understand how these processes contribute to arenavirus pathogenicity.